Discovery of novel TMPRSS2 inhibitors for COVID-19 using in silico fragment-based drug design, molecular docking, molecular dynamics, and quantum mechanics studies

Discovery of novel TMPRSS2 inhibitors for COVID-19 using in silico fragment-based drug design, molecular docking, molecular dynamics, and quantum mechanics studies

The global expansion of COVID-19 and the mutations of severe acute respiratory syndrome coronavirus necessitate quick development of treatment and vaccination. Because the androgen-responsive serine protease TMPRSS2 is involved in cleaving the SARS-CoV-2 spike protein allowing the virus to enter the...

Descrición completa

Detalles Bibliográficos
Main Authors: Abdulrahim A. Alzain, PhD, Fatima A. Elbadwi, Fatima O. Alsamani
Formato: Artigo
Idioma:English
Publicado: Elsevier 2022-01-01
Series:Informatics in Medicine Unlocked
Subjects:
SARS-CoV-2
TMPRSS2
Fragment-based drug design
Homology modeling
Docking
Molecular dynamics
Acceso en liña:http://www.sciencedirect.com/science/article/pii/S2352914822000247

Títulos similares

Títulos similares